{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T14:54:23Z","timestamp":1792853663408,"version":"4.5.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:00:00Z","timestamp":1735776000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","award":["7252144"],"award-info":[{"award-number":["7252144"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370203"],"award-info":[{"award-number":["82370203"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.canlet.2025.217440","type":"journal-article","created":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T02:52:50Z","timestamp":1735786370000},"page":"217440","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["The burden of multiple myeloma in China: Trends from 1990 to 2021 and forecasts for 2050"],"prefix":"10.1016","volume":"611","author":[{"given":"Xuelin","family":"Dou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guixiang","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanting","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinlei","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maigeng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.canlet.2025.217440_bib1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41572-024-00529-7","article-title":"Multiple myeloma","volume":"10","author":"Malard","year":"2024","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.canlet.2025.217440_bib2","doi-asserted-by":"crossref","DOI":"10.1002\/ajh.27422","article-title":"Multiple myeloma: 2024 update on diagnosis, risk-stratification, and management","author":"Rajkumar","year":"2024","journal-title":"Am. J. Hematol."},{"issue":"7","key":"10.1016\/j.canlet.2025.217440_bib3","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/ajh.24402","article-title":"Multiple myeloma: 2016 update on diagnosis, risk-stratification, and management","volume":"91","author":"Rajkumar","year":"2016","journal-title":"Am. J. Hematol."},{"issue":"5","key":"10.1016\/j.canlet.2025.217440_bib4","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.3390\/curroncol30050334","article-title":"Management of multiple myeloma: a review for General practitioners in oncology","volume":"30","author":"Monteith","year":"2023","journal-title":"Curr. Oncol."},{"issue":"6","key":"10.1016\/j.canlet.2025.217440_bib5","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1182\/blood-2007-10-078022","article-title":"Multiple myeloma","volume":"111","author":"Kyle","year":"2008","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.canlet.2025.217440_bib6","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.canlet.2025.217440_bib7","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1186\/s12885-021-08280-y","article-title":"Measuring the global, regional, and national burden of multiple myeloma from 1990 to 2019","volume":"21","author":"Zhou","year":"2021","journal-title":"BMC Cancer"},{"issue":"9","key":"10.1016\/j.canlet.2025.217440_bib8","doi-asserted-by":"crossref","first-page":"e1406","DOI":"10.1634\/theoncologist.2020-0141","article-title":"Multiple myeloma incidence and mortality around the globe; interrelations between health access and quality, economic resources, and patient empowerment","volume":"25","author":"Ludwig","year":"2020","journal-title":"Oncol."},{"key":"10.1016\/j.canlet.2025.217440_bib9","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.14.04033","article-title":"Global, regional, and national burden and quality of care of multiple myeloma, 1990-2019","volume":"14","author":"Geng","year":"2024","journal-title":"J Glob Health"},{"issue":"1","key":"10.1016\/j.canlet.2025.217440_bib10","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-47906-y","article-title":"A population-based study on incidence trends of myeloma in the United States over 2000\u20132020","volume":"13","author":"Mousavi","year":"2023","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.canlet.2025.217440_bib11","doi-asserted-by":"crossref","first-page":"e670","DOI":"10.1016\/S2352-3026(22)00165-X","article-title":"The epidemiological landscape of multiple myeloma: a global cancer registry estimate of disease burden, risk factors, and temporal trends","volume":"9","author":"Huang","year":"2022","journal-title":"The Lancet Haematology"},{"issue":"23","key":"10.1016\/j.canlet.2025.217440_bib12","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1097\/CM9.0000000000002600","article-title":"Burden of multiple myeloma in China: an analysis of the global burden of disease, injuries, and risk factors study 2019","volume":"136","author":"Liu","year":"2023","journal-title":"Chin Med J (Engl)"},{"issue":"1","key":"10.1016\/j.canlet.2025.217440_bib13","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s13045-019-0807-5","article-title":"Incidence and mortality of multiple myeloma in China, 2006-2016: an analysis of the global burden of disease study 2016","volume":"12","author":"Liu","year":"2019","journal-title":"J. Hematol. Oncol."},{"issue":"10258","key":"10.1016\/j.canlet.2025.217440_bib14","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019 [J]","volume":"396","author":"Vos","year":"2020","journal-title":"Lancet"},{"issue":"10440","key":"10.1016\/j.canlet.2025.217440_bib15","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1016\/S0140-6736(24)00769-4","article-title":"Findings from the global burden of disease study 2021","volume":"403","author":"Murray","year":"2024","journal-title":"Lancet"},{"issue":"10440","key":"10.1016\/j.canlet.2025.217440_bib16","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/S0140-6736(24)00476-8","volume":"403","author":"Schumacher","year":"2024","journal-title":"Lancet"},{"issue":"10440","key":"10.1016\/j.canlet.2025.217440_bib17","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1016\/S0140-6736(24)00685-8","article-title":"Burden of disease scenarios for 204 countries and territories, 2022\u20132050: a forecasting analysis for the Global Burden of Disease Study 2021 [J]","volume":"403","author":"Vollset","year":"2024","journal-title":"Lancet"},{"issue":"10159","key":"10.1016\/j.canlet.2025.217440_bib18","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1016\/S0140-6736(18)31694-5","article-title":"Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories","volume":"392","author":"Foreman","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.canlet.2025.217440_bib19","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.gloenvcha.2016.05.009","article-title":"The Shared Socioeconomic Pathways and their energy, land use, and greenhouse gas emissions implications: an overview","volume":"42","author":"Riahi","year":"2017","journal-title":"Global Environ. Change"},{"issue":"3","key":"10.1016\/j.canlet.2025.217440_bib20","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s10584-013-0906-1","article-title":"A new scenario framework for Climate Change Research: scenario matrix architecture","volume":"122","author":"VAN Vuuren","year":"2014","journal-title":"Climatic Change"},{"issue":"10159","key":"10.1016\/j.canlet.2025.217440_bib21","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1016\/S0140-6736(18)31694-5","article-title":"Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016\u201340 for 195 countries and territories [J]","volume":"392","author":"Foreman","year":"2018","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.canlet.2025.217440_bib22","first-page":"531","article-title":"The occurrence of lung cancer in man","volume":"9","author":"Levin","year":"1953","journal-title":"Acta Unio Int. Contra Cancrum"},{"issue":"1","key":"10.1016\/j.canlet.2025.217440_bib23","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12940-019-0492-4","article-title":"Estimation and application of population attributable fraction in ecological studies","volume":"18","author":"Lin","year":"2019","journal-title":"Environmental Health"},{"key":"10.1016\/j.canlet.2025.217440_bib24","series-title":"China's Most Productive Provinces and Cities as Per 2021 GDP Statistics","year":"2022"},{"issue":"9","key":"10.1016\/j.canlet.2025.217440_bib25","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1001\/jamaoncol.2018.2128","article-title":"Global burden of multiple myeloma: a systematic analysis for the global burden of disease study 2016","volume":"4","author":"Cowan","year":"2018","journal-title":"JAMA Oncol."},{"issue":"12","key":"10.1016\/j.canlet.2025.217440_bib26","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.3324\/haematol.2023.282905","article-title":"Cancer-specific mortality in multiple myeloma: a population-based retrospective cohort study","volume":"108","author":"Mccurdy","year":"2023","journal-title":"Haematologica"},{"key":"10.1016\/j.canlet.2025.217440_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217114","article-title":"Gender differences in gliomas: from epidemiological trends to changes at the hormonal and molecular levels","volume":"598","author":"Yin","year":"2024","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.canlet.2025.217440_bib28","doi-asserted-by":"crossref","first-page":"335","DOI":"10.4062\/biomolther.2018.103","article-title":"Sex differences in cancer: epidemiology, genetics and therapy","volume":"26","author":"Kim","year":"2018","journal-title":"Biomol Ther (Seoul)"},{"issue":"4","key":"10.1016\/j.canlet.2025.217440_bib29","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.trecan.2022.01.013","article-title":"The spectrum of sex differences in cancer","volume":"8","author":"Rubin","year":"2022","journal-title":"Trends in Cancer"},{"key":"10.1016\/j.canlet.2025.217440_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1441965","article-title":"Editorial: sex differences in cancer incidence, mortality, and survival: methodological perspectives","volume":"14","author":"Raza","year":"2024","journal-title":"Front. Oncol."},{"issue":"9","key":"10.1016\/j.canlet.2025.217440_bib31","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1002\/ajh.27422","article-title":"Multiple myeloma: 2024 update on diagnosis, risk-stratification, and management","volume":"99","author":"Rajkumar","year":"2024","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.canlet.2025.217440_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216660","article-title":"Delivery of CD47-SIRP\u03b1 checkpoint blocker by BCMA-directed UCAR-T cells enhances antitumor efficacy in multiple myeloma","volume":"585","author":"Lu","year":"2024","journal-title":"Cancer Lett."},{"issue":"8","key":"10.1016\/j.canlet.2025.217440_bib33","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa1903455","article-title":"Oral selinexor\u2013dexamethasone for triple-class refractory multiple myeloma","volume":"381","author":"Chari","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2025.217440_bib34","doi-asserted-by":"crossref","unstructured":"Facon T, Dimopoulos M-A, Leleu X P, et al. Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma [J]. N. Engl. J. Med., 0(0). https:\/\/doi.org\/10.1056\/NEJMoa2400712.","DOI":"10.1056\/NEJMoa2400712"},{"issue":"22","key":"10.1016\/j.canlet.2025.217440_bib35","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1182\/blood-2017-06-788786","article-title":"Efficacy of venetoclax as targeted therapy for relapsed\/refractory t(11;14) multiple myeloma","volume":"130","author":"Kumar","year":"2017","journal-title":"Blood"},{"issue":"32","key":"10.1016\/j.canlet.2025.217440_bib36","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1200\/JCO.21.00443","article-title":"Phase I study of venetoclax plus daratumumab and dexamethasone, with or without bortezomib, in patients with relapsed or refractory multiple myeloma with and without t(11;14","volume":"39","author":"Bahlis","year":"2021","journal-title":"J. Clin. Oncol. : official journal of the American Society of Clinical Oncology"},{"issue":"8","key":"10.1016\/j.canlet.2025.217440_bib37","doi-asserted-by":"crossref","first-page":"e374","DOI":"10.1016\/S1470-2045(24)00094-9","volume":"25","author":"Lin","year":"2024","journal-title":"Lancet Oncol."},{"issue":"5","key":"10.1016\/j.canlet.2025.217440_bib38","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa2403407","article-title":"Belantamab mafodotin, pomalidomide, and dexamethasone in multiple myeloma","volume":"391","author":"Dimopoulos","year":"2024","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.canlet.2025.217440_bib39","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/s41375-021-01453-5","article-title":"Mortality trends in multiple myeloma after the introduction of novel therapies in the United States","volume":"36","author":"Binder","year":"2022","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.canlet.2025.217440_bib40","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa2303379","article-title":"Cilta-cel or standard care in lenalidomide-refractory multiple myeloma","volume":"389","author":"San-Miguel","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.canlet.2025.217440_bib41","doi-asserted-by":"crossref","first-page":"e216","DOI":"10.1016\/S2352-3026(24)00005-X","volume":"11","author":"Delforge","year":"2024","journal-title":"The Lancet Haematology"},{"issue":"3","key":"10.1016\/j.canlet.2025.217440_bib42","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1016\/S2468-2667(18)30267-6","article-title":"Emerging cancer trends among young adults in the USA: analysis of a population-based cancer registry","volume":"4","author":"Sung","year":"2019","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.canlet.2025.217440_bib43","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.canlet.2021.09.004","article-title":"Worldwide distribution, associated factors, and trends of gallbladder cancer: a global country-level analysis","volume":"521","author":"Huang","year":"2021","journal-title":"Cancer Lett."},{"issue":"8","key":"10.1016\/j.canlet.2025.217440_bib44","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.28171","article-title":"Patterns in cancer incidence among people younger than 50 Years in the US, 2010 to 2019","volume":"6","author":"Koh","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.canlet.2025.217440_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217162","article-title":"Enhanced cytokine signaling and ferroptosis defense interplay initiates obesity-associated pancreatic ductal adenocarcinoma","volume":"601","author":"Ruze","year":"2024","journal-title":"Cancer Lett."},{"issue":"6","key":"10.1016\/j.canlet.2025.217440_bib46","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1200\/JCO.23.01751","article-title":"Burden of morbidity and mortality in adolescent and young adult cancer survivors","volume":"42","author":"Armenian","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2025.217440_bib47","article-title":"Patients age 40 Years and younger with multiple myeloma have the same prognosis as older patients: an analysis of real-world patients' evidence from Latin America","volume":"9","author":"Mart\u00ednez-Cordero","year":"2023","journal-title":"JCO Glob Oncol"},{"issue":"3","key":"10.1016\/j.canlet.2025.217440_bib48","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1001\/jama.2024.11146","article-title":"Interventions for high body mass index in children and adolescents: US preventive services task force recommendation statement","volume":"332","author":"Nicholson","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.canlet.2025.217440_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.216035","article-title":"The molecular link between obesity and genomic instability in cancer development","volume":"555","author":"An","year":"2023","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.canlet.2025.217440_bib50","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nrcardio.2017.154","article-title":"Epidemiology of cardiovascular disease in young individuals","volume":"15","author":"Andersson","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.canlet.2025.217440_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1404135","article-title":"Global burden and trends of leukemia attributable to high body mass index risk in adults over the past 30 years","volume":"14","author":"Xiao","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2025.217440_bib52","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.semcancer.2023.04.003","article-title":"Obesity and multiple myeloma: emerging mechanisms and perspectives","volume":"92","author":"Tentolouris","year":"2023","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.canlet.2025.217440_bib53","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.semcancer.2023.04.003","article-title":"Obesity and multiple myeloma: emerging mechanisms and perspectives","volume":"92","author":"Tentolouris","year":"2023","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.canlet.2025.217440_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216403","article-title":"FABP4 in macrophages facilitates obesity-associated pancreatic cancer progression via the NLRP3\/IL-1\u03b2 axis","volume":"575","author":"Yang","year":"2023","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.canlet.2025.217440_bib55","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1186\/s12916-022-02596-7","article-title":"Relationship of body mass index with frailty and all-cause mortality among middle-aged and older adults","volume":"20","author":"Jayanama","year":"2022","journal-title":"BMC Med."},{"key":"10.1016\/j.canlet.2025.217440_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102848","article-title":"Burden of disease attributable to high body mass index: an analysis of data from the Global Burden of Disease Study 2021","volume":"76","author":"Zhou","year":"2024","journal-title":"eClinicalMedicine"},{"issue":"9","key":"10.1016\/j.canlet.2025.217440_bib57","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.1111\/dom.15748","article-title":"The global burden of disease attributable to high body mass index in 204 countries and territories: findings from 1990 to 2019 and predictions to 2035","volume":"26","author":"Chen","year":"2024","journal-title":"Diabetes Obes. Metabol."},{"issue":"10204","key":"10.1016\/j.canlet.2025.217440_bib58","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/S0140-6736(19)30427-1","article-title":"Mortality, morbidity, and risk factors in China and its provinces, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"394","author":"Zhou","year":"2019","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.canlet.2025.217440_bib59","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1158\/1055-9965.EPI-19-0389","article-title":"Association of BMI, smoking, and alcohol with multiple myeloma mortality in asians: a pooled analysis of more than 800,000 participants in the asia cohort consortium","volume":"28","author":"Ugai","year":"2019","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"10","key":"10.1016\/j.canlet.2025.217440_bib60","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-075437","article-title":"Changing trends of the diseases burden attributable to high BMI in Asia from 1990 to 2019: results from the global burden of disease study 2019","volume":"13","author":"Li","year":"2023","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.canlet.2025.217440_bib61","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-73522-5","article-title":"Trends and social determinants of the obesity epidemic among reproductive-age women in ten Asian countries","volume":"14","author":"Thapa","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2025.217440_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216793","article-title":"Disparities in mortality risk after diagnosis of hematological malignancies in 185 countries: a global data analysis","volume":"595","author":"Yang","year":"2024","journal-title":"Cancer Lett."},{"issue":"10440","key":"10.1016\/j.canlet.2025.217440_bib63","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/S0140-6736(24)00932-2","article-title":"Forecasting the global burden of disease to 2050","volume":"403","author":"Zhou","year":"2024","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.canlet.2025.217440_bib64","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1038\/s41591-022-01990-1","article-title":"The global burden of disease study at 30 years","volume":"28","author":"Murray","year":"2022","journal-title":"Nat. Med."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383525000047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383525000047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T22:58:28Z","timestamp":1760741908000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383525000047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":64,"alternative-id":["S0304383525000047"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2025.217440","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The burden of multiple myeloma in China: Trends from 1990 to 2021 and forecasts for 2050","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2025.217440","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"217440"}}